13F filer · CIK 1586444
BLUE JAY CAPITAL MANAGEMENT, LLC
Los Angeles, CA · filing since Q4 2014 · last filing Aug 11, 2017
Reported value
$146.8M
$-56.7M vs prior
Positions
20
New / sold out
9 / 10
Added / reduced
3 / 8
Turnover
32.1%
buys $56.1M · sells $120.5M
Top-10 weight
58.4%
Biggest buys vs Q1 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | QIAGEN NV | +217,954 | – | +$7.3M |
| New | SMITH & NEPHEW PLC | +200,000 | – | +$7.0M |
| New | PORTOLA PHARMACEUTICALS | +120,000 | – | +$6.7M |
| New | NEUROCRINE BIOSCIENCES INC | +145,303 | – | +$6.7M |
| New | BROOKDALE SENIOR LIVING INC | +450,000 | – | +$6.6M |
| New | ICON PLC ORD | +63,342 | – | +$6.2M |
| New | ALIGN TECHNOLOGY INC | +33,904 | – | +$5.1M |
| New | ILLUMINA INC | +27,500 | – | +$4.8M |
| New | INTUITIVE SURGICAL INC | +5,000 | – | +$4.7M |
| Added | WRIGHT MED GROUP N V | +14,255 | +4.7% | +$391.9K |
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2017
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | BIOGEN INC | -46,320 | -100.0% | $-12.7M |
| Sold out | GLOBUS MED INC | -400,000 | -100.0% | $-11.8M |
| Sold out | QIAGEN NV | -390,000 | -100.0% | $-11.3M |
| Sold out | BRISTOL MYERS SQUIBB CO | -200,000 | -100.0% | $-10.9M |
| Sold out | BARD C R INC | -37,419 | -100.0% | $-9.3M |
| Sold out | NUVASIVE INC | -123,317 | -100.0% | $-9.2M |
| Sold out | CELGENE CORP | -72,902 | -100.0% | $-9.1M |
| Sold out | ALLSCRIPTS HEALTHCARE SOLUTN | -590,000 | -100.0% | $-7.5M |
| Sold out | AKORN INC | -300,000 | -100.0% | $-7.2M |
| Sold out | DERMIRA INC | -210,000 | -100.0% | $-7.2M |
8 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2017
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | TESARO INCCOMMON STOCKS | 67,490 | $9.4M | 6.43% |
| 2 | CLOVIS ONCOLOGY INCCOMMON STOCKS | 99,101 | $9.3M | 6.32% |
| 3 | INCYTE CORPCOMMON STOCKS | 72,051 | $9.1M | 6.18% |
| 4 | IRONWOOD PHARMACEUTICALS INCCOMMON STOCKS | 470,000 | $8.9M | 6.05% |
| 5 | WRIGHT MED GROUP N VCOMMON STOCKS | 320,420 | $8.8M | 6.00% |
| 6 | BIOMARIN PHARMACEUTICAL INCCOMMON STOCKS | 94,454 | $8.6M | 5.84% |
| 7 | PRA HEALTH SCIENCES INCCOMMON STOCKS | 106,555 | $8.0M | 5.45% |
| 8 | EDWARDS LIFESCIENCES CORPCOMMON STOCKS | 67,266 | $8.0M | 5.42% |
| 9 | ABIOMED INCCOMMON STOCKS | 55,387 | $7.9M | 5.41% |
| 10 | NEVRO CORPCOMMON STOCKS | 105,000 | $7.8M | 5.33% |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.